Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayApr 21, 2017 11:42 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) Enters $3.72 Million Securities Purchase Agreement

Internet advertising company Social Reality, Inc. (NASDAQ: SRAX) this morning announced its entry into a definitive securities purchase agreement with certain institutional and accredited investors for the purchase and sale of up to an aggregate of $3.72 million principal amount Secured Convertible Debentures and five year Series A Warrants representing the right to acquire up to 1,156,667 shares of the company’s Class A common stock in a transaction exempt from registration under the Securities Act of 1933. “This capital infusion satisfies certain current obligations, eliminates uncertainty of the variable priced financial instrument and provides us working capital to continue to…

Continue Reading

FridayApr 21, 2017 11:15 am

NetworkNewsBreaks – Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) Prices $15M Public Offering

Adamis Pharmaceuticals (NASDAQ: ADMP) this morning priced its previously announced underwritten public offering of 4,285,715 shares of its common stock at $3.50 per share for gross proceeds of approximately $15 million. The offering is expected to close on April 26, 2017. Underwriters have an option to purchase up to 642,857 additional shares to cover over-allotments, if any. Adamis said it plans to use the proceeds for general corporate purposes. To view the full press release, visit: http://nnw.fm/bC094 About Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of…

Continue Reading

ThursdayApr 20, 2017 2:19 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SIGA 11.46% – News: Completes enrollment and dosing in phase 1 study MOMT 8.89% – News: Appoints new member to board of directors FSNN 6.90% – News: Secures $2.1M, five-year cloud solutions contract with leading health system APDN 6.25% – News: Enters bulk DNA supply agreement with leading chemicals company CGNT 5.99% – News: Appoints new SVP of marketing and business development IDXG 5.90% – News: Eliminates long-term secured debt KSHB 5.02% – News:…

Continue Reading

ThursdayApr 20, 2017 12:16 pm

NetworkNewsBreaks – Atossa Genetics, Inc.’s (NASDAQ: ATOS) Phase 1 Endoxifen Study Receives Positive Interim Review

Atossa Genetics (NASDAQ: ATOS) this morning said it has received a positive interim review on its phase 1 study of endoxifen, an active metabolite of the FDA-approved drug tamoxifen, indicated for breast cancer and breast cancer prevention in high risk patients. Upon reviewing the blinded data generated from the first cohort of the study of eight subjects, the Independent Safety Committee concluded that the study may advance to the next dosing level. "It is the first assessment of our clinical safety and tolerability data and it indicates that proceeding to the next dosing level with our proprietary topical Endoxifen is…

Continue Reading

ThursdayApr 20, 2017 12:14 pm

NetworkNewsBreaks – MicroVision, Inc. (NASDAQ: MVIS) Secures $24M Contract for Laser Beam Scanning System by Leading Tech Company

MicroVision (NASDAQ: MVIS) shares are up 16% this morning after the company announced its contract with a major technology company to develop a Laser Beam Scanning (LBS) display system and to produce MicroVision specific components. Per the agreement, the company will develop a new generation of MEMS, ASICs and related firmware for a high resolution, LBS-based product the technology company is planning to produce. MicroVision will receive up to $24 million, including $14 million in fees for development work that is expected to span 21 months and an upfront payment for other items. The development fees would be paid upon…

Continue Reading

ThursdayApr 20, 2017 12:11 pm

NetworkNewsBreaks – Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) Inks LOI with Pint Pharma; Shares Climb

Immune Pharmaceuticals (NASDAQ: IMNP) shares are up more than 48% in late morning trade following news the company has entered into a letter of intent with Pint Pharma GmnH regarding the pursuit of an exclusive license by Pint of the rights to commercialize Ceplene throughout Latin America. The companies anticipate the close of the final agreement will occur within 30 days. Per the final agreement, Pint will carry out the full commercialization of the licensed product in the territory, including Ceplene registration, pricing and reimbursement, and sales and marketing activities. At the time of the final agreement, Pint will also…

Continue Reading

ThursdayApr 20, 2017 12:07 pm

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Launches Updated Apps with Integrated UnionPay Payment Modules

Online-to-offline (O2O) integrated social media platform operator Moxian, Inc. (NASDAQ: MOXC) this morning announced the launch of new versions of its Moxian User App and Business App that feature built-in UnionPay payment modules. This update follows Moxian’s previously announced strategic partnership with Beijing Chinaums, a subsidiary of China UnionPay. “The implementation of UnionPay into our App is a big game changer in our strategy,” James Tan, chairman and CEO of Moxian, noted in this morning’s news release. “Through various methods, we are able to capture both users and merchants by enticing users to spend at merchant stores, which in-turn boost…

Continue Reading

ThursdayApr 20, 2017 9:45 am

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Announces Results from Independent Testing of Proprietary Lithium Extraction Process

Diversified mining company MGX Minerals, Inc. (OTC: MGXMF) this morning announced that it has received independent laboratory-testing results from the Saskatchewan Research Council (“SRC”) regarding its patent-pending “Method for Extraction of Lithium from Salt Brine” (U.S. Provisional Patent #62/419,011). The results from the SRC noted that MGX’s proprietary extraction process was successful in recovering up to 83.7% lithium and concentrating 461 ppm lithium from a 71 ppm representative sample of formation brine originating from the Sturgeon Lake oilfield. “The results of laboratory testing by SRC provide third-party validation of our proprietary design process and its ability to rapidly separate lithium…

Continue Reading

WednesdayApr 19, 2017 12:37 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: HDYN 22.95% – News: Signs third amendment to production sharing contract with SAPETRO and the Republic of Guinea; Names new senior VP and CFO CYTR 15.48% – News: Reaches agreement with FDA on aldoxorubicin NDA to treat STS HIPC 8.79% – News: Completes second round of financing WSTL 5.13% – News: Selected to support 2017 New York City subway project by Transit Wireless VPRB 4.74% – News: Launches new online retail portal, opens new…

Continue Reading

WednesdayApr 19, 2017 11:15 am

NetworkNewsBreaks – Marathon Patent Group, Inc. (NASDAQ: MARA) Prices $2.66M Synchronized Registered Direct Offering and Private Placement

Marathon Patent Group (NASDAQ: MARA) recently entered into definitive agreements with investors for the purchase and sale of 3,800,000 shares of common stock at a price of $0.70 per share in a registered direct offering, as well as warrants to purchase up to 2,280,000 shares of common stock at an effective price of $0.01 per warrant with an exercise price of $0.83 per share in a concurrent private placement. Gross proceeds of the offerings are expected to be approximately $2,660,000 before fees, expenses and placement agent discounts. The company plans to use the net proceeds for working capital and other…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000